A Canadian medical board recommended this week that government health plans cover the cost of abortion drugs for women across the country.
Metro News reports the Canadian Drug Expert Committee released its recommendations in a report Thursday. One province, New Brunswick, already is making plans to begin giving the abortion drugs to women free of charge through its taxpayer-funded health system.
Canada, like the United States, has some of the most liberal abortion laws in the world, basically allowing abortions for any reason through all nine months of pregnancy. The new recommendation, if implemented, would lead to even more unborn babies’ lives being destroyed.
Canadian health officials approved the dangerous abortion drugs for use in 2015; and the drugs became available to Canadians in January, The Canadian Press reports. The abortion drugs mifegymiso, a two-drug combination of RU-486 (mifepristone) and misoprostol, typically costs between $300 and $450.
The first abortion drug works by blocking the hormone progesterone, causing the uterine wall to break down and basically suffocating the unborn baby. The second drug then induces contractions to expel the unborn child’s body. This abortion method typically is used during the first 10 weeks of pregnancy.
Follow LifeNews.com on Instagram for pro-life pictures.
Last month, the Canadian drug review board considered the safety, effectiveness and value of the abortion drugs in making its recommendation. The board concluded that the abortion drugs should be covered by government health plans because they are safe and effective for women, CBC reports.
Here’s more from the report:
The recommendation that the governments should pay for Mifegymiso is non-binding, and provinces can choose to fund the drug solely for women who are covered by public drug plans such as those on social assistance, or for every women who is prescribed it.
Mifegymiso sells for approximately $300. However, the approval of the drug by CADTH means the pan-Canadian Pharmaceutical Alliance — a joint government drug-price negotiating body — will likely begin talks with the manufacturer for a group discount.
When New Brunswick announced its plans several weeks ago, Heather Hughes, the executive director of New Brunswick Right to Life, said she felt distressed.
“For a province that is already cash-strapped … where does this money come from?” she told The Globe and Mail. “Why is the government so determined to put money into abortion as birth control when they know that New Brunswickers are opposed to that?”
For many years, U.S. polls have shown strong opposition to taxpayer funding of abortions. Canadian polling on the issue appears scarce. A 2011 poll by the Canadian group LifeCanada found 54 percent of Canadians said abortions should be funded by tax dollars only in cases of medical emergencies.
While the drugs are new in Canada, the U.S. approved the dangerous abortion drugs many years ago under pro-abortion President Bill Clinton. Last year, under pro-abortion President Barack Obama, the FDA expanded its guidelines for the abortion drugs, allowing them to be used later in pregnancy and in lower doses.
An FDA study from 2011 found that RU-486 is responsible for the deaths of at least 14 women in the U.S. and dozens more worldwide. In the April 2011 report, the FDA found that 2,207 women in the U.S. also were injured by the drug. A Planned Parenthood study also admits at least one woman is seriously injured from the abortion drug daily.
RU-486 has claimed the lives of more than 2 million unborn children in the United States since its approval at the end of the Clinton administration.
